Skip to main content

CANNABIDIOL COMO ACELERADOR DE LA RESPUESTA FARMACOLOGICA ANTIDEPRESIVA: UNA VIA HACIA LA IDENTIFICACION DE LOS MECANISMOS CELULARES IMPLICADOS EN LA DEPRESION.

SAF2015-67457-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre UNIVERSIDAD DE CANTABRIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Enhanced stress response in 5-HT1AR overexpressing mice: Altered HPA function and hippocampal long-term potentiation

  • Pilar-Cuéllar, Fuencisla
  • Vidal, Rebeca
  • Díaz, Álvaro
  • Linge, Raquel
  • Castro, Elena
  • Romero-Presno, Beatriz
  • Crespo-Facorro, Benedicto
  • Pazos, Ángel
Pilar-Cuéllar, Fuencisla et al., Postsynaptic 5-HT receptors (5-HTR) play an important role in anxiety and stress, although their contribution is still controversial. Previous studies report that mice overexpressing postsynaptic 5-HTRs show no changes in basal anxiety, though the influence of stress conditions has not been addressed yet. In this study, we used this animal model to evaluate the role of 5-HTRs in anxiety response after pre-exposure to an acute stressor. Under basal conditions, 5-HTR overexpressing animals presented high corticosterone levels and a lower mineralocorticoid/glucocorticoid receptor ratio. After pre-exposure to a single stressor, they showed a high anxiety-like response, associated with a blunted increase in corticosterone levels and higher c-Fos activation in the prefrontal cortex. Moreover, these mice also presented a lack of downregulation of hippocampal long-term potentiation after stress exposure. Therefore, higher postsynaptic 5-HTR activation might predispose to a high anxious phenotype and an impaired stress coping behavior., This research was supported by the Spanish Ministry of Economy and Competitiveness (SAF2011-25020 and SAF2015-67457-R), Instituto de Salud Carlos III (FIS Grant PI13-00038), cofunded by the European Regional Development Fund (“A way to build Europe”), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Effect of mTOR silencing in mouse infralimbic cortex on depressive-like behaviour

  • Garro-Martínez, Emilio
  • Fullana, Neus
  • Paz, Verónica
  • Ruiz-Bronchal, Esther
  • Pazos, Ángel
  • Pilar-Cuéllar, Fuencisla
Póster presentado al 30th ECNP Congress: "For the science and treatment of disorders of the brain", celebrado en Paris del 2 al 5 de septiembre de 2017., Among the hypotheses postulated with the aim of clarifying the neurobiological basis of major depressive disorder (MDD), the neurotrophic hypothesis is one of the most accepted. The extremely important role of trophic factors such as the brain derived neurotrophic factor (BNDF) in both, the etiopatology and the antidepressant effect, is well known. However, in recent decades, the intracellular pathways related to neural proliferation and plasticity have gained strength in the field. In this regard, increased activation of mammalian target of rapamycin (mTOR) pathway in the medial prefrontal cortex (mPFC), is necessary for the rapid antidepressant effect of the NMethyl-D-aspartate (NMDA) antagonist ketamine., Supported by Spanish Ministry of Economy and Competitiveness (SAF2011-25020 and SAF2015-67457-R)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Antidepressant-like effects of the AMPA potentiator S47445 are associated with changes in hippocampal BDNF and mTOR signaling in bulbectomy mouse model

  • Pilar-Cuéllar, Fuencisla
  • Castro, Elena
  • Bretin, S.
  • Mocaer, E.
  • Pazos, Ángel
  • Díaz, Álvaro
Póster presentado al 30th ECNP Congress: "For the science and treatment of disorders of the brain", celebrado en Paris del 2 al 5 de septiembre de 2017., The positive allosteric modulator of glutamate AMPA-type receptors S47445 increases neurotrophic levels, enhancing synaptic plasticity and procognitive functions in aged rodent models. Moreover, the chronic administration of this compound induces antidepressant- and anxiolytic-like effects in a wide variety of animal models of depression. Here, we have assessed the behavioral effects on depression and anxiety paradigms after the chronic administration of S47445 in the bilateral olfactory bulbectomy (OBX) mice model of depression. In addition, we have evaluated the changes in neurotrophic (BDNF) and neuroplastic markers (mTOR pathway) in the hippocampus, which are associated to the antidepressant effect., Supported by Spanish Ministry of Economy and Competitiveness (SAF2011-25020 and SAF2015-67457-R)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice

  • Pilar-Cuéllar, Fuencisla
  • Castro, Elena
  • Bretin, S.
  • Mocaer, E.
  • Pazos, Ángel
  • Díaz, Álvaro
S 47445 is a positive allosteric modulator of glutamate AMPA-type receptors that possesses procognitive, neurotrophic and enhancing synaptic plasticity properties. Its chronic administration promotes antidepressant- and anxiolytic-like effects in different rodent models of depression. We have evaluated the behavioral effects of S 47445 in the bilateral olfactory bulbectomy mice model (OB) and the adaptive changes in those proteins associated to brain neuroplasticity (BDNF and mTOR pathway). Following OB surgery, adult C57BL/6J male mice were chronically administered S 47445 (1, 3 and 10 mg/kg/day; i.p.) and fluoxetine (18 mg/kg/day; i.p.), and then behaviorally tested in the open field test. Afterwards, the expression levels of BDNF, mTOR, phospho-mTOR, 4EBP1 and phospho-4EBP1 were evaluated in hippocampus and prefrontal cortex. Both drugs reduced the OB-induced locomotor activity, a predictive outcome of antidepressant efficacy, with a similar temporal pattern of action. S 47445, but not fluoxetine, showed an anxiolytic effect as reflected by an increased central activity. Chronic administration of S 47445 reversed OB-induced changes in BDNF and phopho-mTOR expression in hippocampus but not in prefrontal cortex. The chronic administration of S 47445 induced antidepressant- and anxiolytic-like effects at low-medium doses (1 and 3 mg/kg/day, i.p.) associated with the reversal of OB-induced changes in hippocampal BDNF and mTOR signaling pathways., This work was supported by the Institut de Recherches Internationales Servier and the Spanish Ministry of Economy and Competitiveness (MINECO/FEDER) (grant number SAF2015–67457-R). Instituto de Salud Carlos III (FIS Grant PI13-00038).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation

  • Vidal, Rebeca
  • Garro-Martínez, Emilio
  • Díaz, Álvaro
  • Castro, Elena
  • Florensa-Zanuy, Eva
  • Taketo, Makoto Mark
  • Pazos, Ángel
  • Pilar-Cuéllar, Fuencisla
β-catenin (key mediator in the Wnt signaling pathway) contributes to the pathophysiology of mood disorders, associated to neurogenesis and neuroplasticity. Decreased β-catenin protein levels have been observed in the hippocampus and prefrontal cortex of depressed subjects. Additionally, the antidepressants exert, at least in part, their neurogenic effects by increasing β-catenin levels in the subgranular zone of the hippocampus. To further understand the role of β-catenin in depression and anxiety, we generated two conditional transgenic mice in which β-catenin was either inactivated or stabilized in cells expressing CreERT under the control of the astrocyte-specific glutamate transporter (GLAST) promoter inducible by tamoxifen, which presents high expression levels on the subgranular zone of the hippocampus. Here, we show that β-catenin inactivation in GLAST-expressing cells enhanced anxious/depressive-like responses. These behavioral changes were associated with impaired hippocampal proliferation and markers of immature neurons as doublecortin. On the other hand, β-catenin stabilization induced an anxiolytic-like effect in the novelty suppressed feeding test and tended to ameliorate depressive-related behaviors. In these mice, the control over the Wnt/β-catenin pathway seems to be tighter as evidenced by the lack of changes in some proliferation markers. Moreover, animals with stabilized β-catenin showed resilience to some anxious/depressive manifestations when subjected to the corticosterone model of depression. Our findings demonstrate that β-catenin present in GLAST-expressing cells plays a critical role in the development of anxious/depressive-like behaviors and resilience, which parallels its regulatory function on hippocampal proliferation. Further studies need to be done to clarify the importance of these changes in other brain areas also implicated in the neurobiology of anxiety and depressive disorders., This research was supported by the Spanish Ministry of Economy and Competitiveness (SAF2011-25020 and SAF2015-67457-R), Instituto de Salud Carlos III (FIS Grant PI13- 00038), co-funded by the European Regional Development Fund (BA way to build Europe^), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System

  • Garro-Martínez, Emilio
  • Vidal, Rebeca
  • Adell, Albert
  • Díaz, Álvaro
  • Castro, Elena
  • Amigó, Josep
  • Gutiérrez-Lanza, Raquel
  • Florensa-Zanuy, Eva
  • Gómez-Acero, Laura
  • Taketo, Makoto Mark
  • Pazos, Ángel
  • Pilar-Cuéllar, Fuencisla
We previously reported that the inactivation (cKO) or the stabilization (cST) of β-catenin in cells expressing the astrocyte-specific glutamate aspartate transporter (GLAST) is associated with the vulnerability or resilience to exhibit anxious/depressive-like behaviors, respectively, and to changes in hippocampal proliferation. Here, we used these cKO and cST β-catenin mice to study the serotonergic system functionality associated with their behavioral/molecular phenotype. The activity of 5-HT receptors was assessed by (+)-8-OH-DPAT-induced hypothermia and [S]GTPγS binding autoradiography. The animals’ response to acute stress and the levels of extracellular serotonin (5-HT) in the medial prefrontal cortex (mPFC) were also assessed. cKO mice presented higher 5-HT autoreceptor functionality, lower 5-HT heteroreceptor functionality, and a decrease in extracellular 5-HT levels in the mPFC. These neurochemical changes were accompanied with a blunted physiological response to stress-induced hyperthermia. In contrast, cST mice showed a reduced 5-HT autoreceptor functionality and higher extracellular 5-HT levels in the mPFC after fluoxetine administration. Moreover, cST mice subjected to chronic corticosterone administration did not show a blunted response to fluoxetine. Our findings suggest the existence of a link between β-catenin levels and 5-HT receptor functionality, which may be relevant to understand the neurobiological bases underlying the vulnerability or resilience to stress-related disorders., This research was supported by the Spanish Ministry of Economy and Competitiveness (SAF2011-25020 and SAF2015-67457-R MINECO/FEDER) and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM CB/07/09/0029). E F-Z and L G-A were supported by a predoctoral fellowship from the University of Cantabria (Spain) and a JAE-Intro (CSIC) fellowship, respectively.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Increased vulnerability to impulsive behavior after streptococcal antigen exposure and antibiotic treatment in rats

  • Mora, Santiago
  • Martín-González, Elena
  • Prados-Pardo, Ángeles
  • Moreno, Joaquín
  • López, María José
  • Pilar-Cuéllar, Fuencisla
  • Castro, Elena
  • Díaz, Álvaro
  • Flores, Pilar
  • Moreno, Margarita
[Rationale]: The inflammation induced by Group A Streptococcus (GAS) infection has been viewed as a vulnerability factor in mental disorders characterized by inhibitory control deficits, such as attention-deficit/hyperactivity disorder or obsessive–compulsive disorder. Antibiotic treatment reduces GAS symptoms; however, its effects on impulsivity have not been fully assessed. Objectives: We investigated whether GAS exposure during early adolescence might be a vulnerability factor for adult impulsivity, if antibiotic treatment acts as a protective factor, and whether these differences are accompanied by changes in the inflammatory cytokine frontostriatal regions. [Methods]: Male Wistar rats were exposed to the GAS antigen or to vehicle plus adjuvants at postnatal day (PND) 35 (with two boosts), and they received either ampicillin (supplemented in the drinking water) or water alone from PND35 to PND70. Adult impulsivity was assessed using two different models, the 5-choice serial reaction time task (5-CSRT task) and the delay discounting task (DDT). The levels of interleukin-6 (IL-6) and IL-17 were measured in the prefrontal cortex (PFc), and the tumor necrosis factor α levels (TNFα) were measured in the PFc and nucleus accumbens (NAcc). [Results]: GAS exposure and ampicillin treatment increased the waiting impulsivity by a higher number of premature responses when the animals were challenged by a long intertrial interval during the 5-CSRT task. The GAS exposure revealed higher impulsive choices at the highest delay (40 s) when tested by DDT, while coadministration with ampicillin prevented the impulsive choice. GAS exposure and ampicillin reduced the IL-6 and IL-17 levels in the PFc, and ampicillin treatment increased the TNFα levels in the NAcc. A regression analysis revealed a significant contribution of GAS exposure and TNFα levels to the observed effects. [Conclusions]: GAS exposure and ampicillin treatment induced an inhibitory control deficit in a different manner depending on the form of impulsivity measured here, with inflammatory long-term changes in the PFc and NAcc that might increase the vulnerability to impulsivity-related neuropsychiatric disorders., This work was supported by grants from the Ministerio de Economía y Competitividad, Spanish Government (grant number PSI2015-70037-R, PGC2018-099117-B-C21 and SAF2015-67457-R; MINECO-FEDER).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Antidepressant-like effect and molecular mechanism of action of cannabidiol in the lipopolysaccharide model of depression in mice

  • Florensa-Zanuy, Eva
  • Architravo, Annamaria
  • Adell, Albert
  • Garro-Martínez, Emilio
  • Castro, Elena
  • Díaz, Álvaro
  • Pazos, Ángel
  • Pilar-Cuéllar, Fuencisla
Resumen del trabajo presentado en el 33rd ECNP Congress Virtual, celebrado en modalidad virtual del 12 al 15 de septiembre de 2020., Major Depression is an incapacitating disease spread worldwide. As its etiology is still unknown, some hypotheses have been postulated, being the neuro-inflammatory one of the most recent. The current treatment for depression is far from optimal and there is an urgent need to find fast-acting drugs with fewer side effects. In this regard, cannabidiol (CBD), the major non-psychotropic component of , appears as a promising antidepressant drug. We have evaluated CBD’s behavioural and molecular effects in a neuro-inflammatory model of depression induced by lipopolysaccharide (LPS)., This research was supported by the Ministerio de Economía y Competitividad (SAF2015-67457-R MINECO/FEDER), the Ministerio de Ciencia Innovación y Universidades (RTI2018-097534-B-I00), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM CB/07/09/0029).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways

  • Florensa-Zanuy, Eva
  • Garro-Martínez, Emilio
  • Adell, Albert
  • Castro, Elena
  • Díaz, Álvaro
  • Pazos, Ángel
  • Mac-Dowell, Karina S.
  • Martín-Hernández, David
  • Pilar-Cuéllar, Fuencisla
Major Depression is a severe psychiatric condition with a still poorly understood etiology. In the last years, evidence supporting the neuroinflammatory hypothesis of depression has increased. In the current clinical scenario, in which the available treatments for depression is far from optimal, there is an urgent need to develop fast-acting drugs with fewer side effects. In this regard, recent pieces of evidence suggest that cannabidiol (CBD), the major non-psychotropic component of Cannabis sativa with anti-inflammatory properties, appears as a drug with antidepressant properties. In this work, CBD 30 mg/kg was administered systemically to mice 30 min before lipopolysaccharide (LPS; 0.83 mg/kg) administration as a neuroinflammatory model, and behavioral tests for depressive-, anhedonic- and anxious-like behavior were performed. NF-ĸB, IκBα and PPARγ levels were analyzed by western blot in nuclear and cytosolic fractions of cortical samples. IL-6 and TNFα levels were determined in plasma and prefrontal cortex using ELISA and qPCR techniques, respectively. The precursor tryptophan (TRP), and its metabolites kynurenine (KYN) and serotonin (5-HT) were measured in hippocampus and cortex by HPLC. The ratios KYN/TRP and KYN/5-HT were used to estimate indoleamine 2,3-dioxygenase (IDO) activity and the balance of both metabolic pathways, respectively. CBD reduced the immobility time in the tail suspension test and increased sucrose preference in the LPS model, without affecting locomotion and central activity in the open-field test. CBD diminished cortical NF-ĸB activation, IL-6 levels in plasma and brain, and the increased KYN/TRP and KYN/5-HT ratios in hippocampus and cortex in the LPS model. Our results demonstrate that CBD produced antidepressant-like effects in the LPS neuroinflammatory model, associated to a reduction in the kynurenine pathway activation, IL-6 levels and NF-ĸB activation. As CBD stands out as a promising antidepressant drug, more research is needed to completely understand its mechanisms of action in depression linked to inflammation., This research was supported by the Ministerio de Economía y Competitividad (SAF2015-67457-R MINECO/FEDER), the Ministerio de Ciencia, Innovacion ´ y Universidades (RTI2018-097534-B-I00), the Instituto de Salud Carlos III (PI19/00170), and Centro de Investigacion ´ Biom´edica en Red de Salud Mental (CIBERSAM). E F-Z was supported by a predoctoral fellowship from the Universidad de Cantabria (Spain).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders

  • Mato, Susana
  • Pilar-Cuéllar, Fuencisla
  • Valdizán, Elsa M.
  • González-Maeso, Javier
  • Rodríguez-Puertas, Rafael
  • Meana, Javier
  • Sallés, Joan
  • Crespo-Facorro, Benedicto
  • Pazos, Ángel
Brain endocannabinoid system is proposed to play a role in the pathogenesis of affective disorders. In the present study, we analyzed the functionality of the cannabinoid receptor type 1 (CB1 receptor) at different transduction levels in prefrontal cortex (PFC) of depressed suicide victims. We examined stimulation of [35S]GTPγS binding, activation of Gα protein subunits and inhibition of adenylyl cyclase by the cannabinoid agonist WIN55,212-2, as well as [3H]CP55,940 binding, in PFC homogenates from suicide victims with major depression (MD) and matched control subjects. CB1 receptor-stimulated [35S]GTPγS binding was significantly greater in the PFC of MD compared with matched controls (23%, p < 0.05). This increase was most evident in the PFC from MD subgroup with negative blood test for antidepressants (AD) at the time of death (AD-free) (38%, p < 0.05), being absent when comparing the AD-treated MD cases with their controls. The density of CB1 receptors and their coupling to adenylyl cyclase were similar between MD and control cases, regardless of the existence of AD intake. Analysis of [35S]GTPγS-labelled Gα subunits allowed for the detection of upregulated CB1 receptor coupling to Gαo, but not to Gαi1, Gαi2, Gαi3, Gαz subunits, in the PFC from AD-free MD suicides. These results suggest that increased CB1 receptor functionality at the Gαi/o protein level in the PFC of MD subjects is due to enhanced coupling to Gαo proteins and might be modulated by AD intake. These data provide new insights into the role of endocannabinoid neurotransmission in the pathobiology of MD and suggest its regulation by ADs., This study was partially supported by the Spanish Ministry of Economy and Competitiveness, Spain (SAF2007/61862, SAF2011-25020 and SAF2015-67457-R, MINECO/FEDER) to AP, SAF 2009-08460 to JJM, and the Basque Government (IT-616-13 to JJM).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The endocannabinoid system in mental disorders: Evidence from human brain studies

  • Ibarra-Lecue, Inés
  • Pilar-Cuéllar, Fuencisla
  • Muguruza, Carolina
  • Florensa-Zanuy, Eva
  • Díaz, Álvaro
  • Urigüen, Leyre
  • Castro, Elena
  • Pazos, Ángel
  • Callado, Luis F.
Mental disorders have a high prevalence compared with many other health conditions and are the leading cause of disability worldwide. Several studies performed in the last years support the involvement of the endocannabinoid system in the etiopathogenesis of different mental disorders. The present review will summarize the latest information on the role of the endocannabinoid system in psychiatric disorders, specifically depression, anxiety, and schizophrenia. We will focus on the findings from human brain studies regarding alterations in endocannabinoid levels, cannabinoid receptors and endocannabinoid metabolizing enzymes in patients suffering mental disorders. Studies carried out in humans have consistently demonstrated that the endocannabinoid system is fundamental for emotional homeostasis and cognitive function. Thus, deregulation of the different elements that are part of the endocannabinoid system may contribute to the pathophysiology of several mental disorders. However, the results reported are controversial. In this sense, different alterations in gene and/or protein expression of CB1 receptors have been shown depending on the technical approach used or the brain region studied. Despite the current discrepancies regarding cannabinoid receptors changes in depression and schizophrenia, present findings point to the endocannabinoid system as a pivotal neuromodulatory pathway relevant in the pathophysiology of mental disorders., This study was supported by the Spanish Ministry of Economy and Competitiveness (SAF2015-67457-R, MINECO/FEDER), the Plan Estatal de I+D+i 2013-2016, the Instituto de Salud Carlos III-Subdirección General de Evaluación y Fomento de la Investigación, Spanish Ministry of Economy, FEDER (PI13/01529) and the Basque Government (IT616/13). I I-L is a recipient of a Predoctoral Fellowship from the Basque Government. E F-Z is a recipient of a Predoctoral Fellowship from the University of Cantabria. CM is a recipient of a Postdoctoral Marie Skłodowska-Curie Individual Fellowship (H2020-MSCA-IF-2016, ID 747487).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

5-HT4Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression

  • Amigó, Josep
  • Garro-Martínez, Emilio
  • Vidal, Rebeca
  • Compan, V.
  • Pilar-Cuéllar, Fuencisla
  • Pazos, Ángel
  • Díaz, Álvaro
  • Castro, Elena
Clinical and preclinical studies report the implication of 5-hydroxytryptamine 4 receptors (5-HT4Rs) in depression and anxiety. Here, we tested whether the absence of 5-HT4Rs influences the response to the antidepressant fluoxetine in mice subjected to chronic corticosterone administration, an animal model of depression and anxiety. Therefore, the effects of chronic administration of fluoxetine in corticosterone-treated wild-type (WT) and 5-HT4R knockout (KO) mice were evaluated in the open-field and novelty suppressed feeding tests. As 5-HT1A receptor (5-HT1AR) and brain-derived neurotrophic factor (BDNF) are critically involved in depression and anxiety, we further evaluated 5-HT1A receptor functionality by [35S]GTPγS autoradiography and BDNF mRNA expression by in situ hybridization techniques. We found that 5-HT4R KO and WT mice displayed anxiety- and depressive-like behavior following chronic administration of corticosterone, as evidenced in the open-field and novelty suppressed feeding tests. In the open-field, a decreased central activity was observed in naı̈ve and corticosterone-treated mice of both genotypes following chronic fluoxetine administration. In the novelty suppressed feeding test, a predictive paradigm of antidepressant activity, chronic treatment with fluoxetine reverted the latency to eat in both genotypes. The antidepressant also potentiated the corticosterone-induced desensitization of the 5-HT1AR in the dorsal raphe nucleus. Further, chronic fluoxetine increased BDNF mRNA expression in the dentate gyrus of the hippocampus in corticosterone-treated mice of both genotypes. Therefore, our findings indicate that the behavioral effects of fluoxetine in the corticosterone model of depression and anxiety appear not to be dependent on 5-HT4Rs., This research was supported by Ministerio de Economía y Competitividad (SAF2011-25020 and SAF2015-67457-R), Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

mTOR knockdown in the infralimbic cortex evokes a depressive-like state in mouse

  • Garro-Martínez, Emilio
  • Fullana, Neus
  • Florensa-Zanuy, Eva
  • Senserrich, Júlia
  • Paz, Verónica
  • Ruiz-Bronchal, Esther
  • Adell, Albert
  • Castro, Elena
  • Díaz, Álvaro
  • Pazos, Ángel
  • Bortolozzi, Analía
  • Pilar-Cuéllar, Fuencisla
Fast and sustained antidepressant effects of ketamine identified the mammalian target of rapamycin (mTOR) signaling pathway as the main modulator of its antidepressive effects. Thus, mTOR signaling has become integral for the preclinical evaluation of novel compounds to treat depression. However, causality between mTOR and depression has yet to be determined. To address this, we knocked down mTOR expression in mice using an acute intracerebral infusion of small interfering RNAs (siRNA) in the infralimbic (IL) or prelimbic (PrL) cortices of the medial prefrontal cortex (mPFC), and evaluated depressive-and anxious-like behaviors. mTOR knockdown in IL, but not PrL, cortex produced a robust depressive-like phenotype in mice, as assessed in the forced swimming test (FST) and the tail suspension test (TST). This phenotype was associated with significant reductions of mTOR mRNA and protein levels 48 h post-infusion. In parallel, decreased brain-derived neurotrophic factor (BDNF) expression was found bilaterally in both IL and PrL cortices along with a dysregulation of serotonin (5-HT) and glutamate (Glu) release in the dorsal raphe nucleus (DRN). Overall, our results demonstrate causality between mTOR expression in the IL cortex and depressive-like behaviors, but not in anxiety., This research was funded by grants of the Ministerio de Economía y Competitividad (SAF2011-25020 and SAF2015-67457-R MINECO); Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00); Ministerio de Ciencia e Innovación (PID2019-105136RB-100); and the European Regional Development Fund (ERDF), UE; Instituto de Salud Carlos III (PI19/00170), and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Autoradiographic Visualization of G Protein-Coupled Receptors in Brain

  • Vidal, Rebeca
  • Pilar-Cuéllar, Fuencisla
  • Díaz, Álvaro
  • Castro, Elena
In this chapter, two in vitro techniques applied to study the anatomical localization of a receptor are revised: firstly, the receptor-binding assay in sections, a technique to assess the location and distribution of a receptor in the tissue (descriptive and anatomical information), and secondly, the [35S]GTPγS-binding assay also in tissue slices, which allows the quantification of the level of G-protein activation by a specific GPCR´s agonist. The latter technique provides additional information about the coupling efficacy of a receptor to G-proteins (functional autoradiography), thus enabling the study of the first step in the intracellular signaling pathway after the receptor activation. Both techniques are basically performed for the in vitro autoradiographic visualization of receptors in tissue slices obtained from animal or human postmortem samples., This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2015-67457-R MINECO/FEDER) (MINECO/FEDER, UE), the Ministry of Science, Innovation and Universities (RTI2018-097534-B-I00) (MCIU/AEI/ FEDER,UE), and the Instituto de Salud Carlos III.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Radioligand Binding Detection of Receptors in Brain Membranes

  • Pilar-Cuéllar, Fuencisla
  • Garro-Martínez, Emilio
  • Castro, Elena
  • Díaz, Álvaro
Transmitters, hormones, and most of the therapeutic drugs exert their biological functions by generating signals in target cells through interaction with a receptor molecule in the cellular membrane, cytosol, or even at the nucleus of the cell. Because receptors play such a crucial role in cell function, especially within the central nervous system (CNS), we need lab techniques to measure their expression and functionality. There are techniques to determine regulatory changes in receptor number (receptor density), subcellular distribution, anatomical distribution, the physiological function of the receptors as well as the ligand affinity. Here, we describe a classic method in which cells or tissue membranes are exposed to radiolabeled molecules (radioligands) that bind selectively to the receptors in the sample (receptor binding assay). Similarly, the functional consequence of the receptor occupancy or level of G protein activation can be measured by [35S]GTPγS binding assay, also known as functional binding. This assay measures the binding of the nonhydrolyzable analog [35S]GTPγS ([35S]guanosine-5′-O-(3-thio) triphosphate) to Gα subunits. The above radiometric assays are useful to determine the affinity and receptor density of a drug, and to differentiate among agonist, antagonist, and inverse agonist activities, the traditional pharmacological parameters of potency and efficacy, as well as receptor constitutive activity. Moreover, radioligand binding assays provide a powerful tool for screening drug candidates for many receptors in drug discovery research., This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2015-67457-R MINECO/FEDER) (MINECO/FEDER, UE), the Ministry of Science, Innovation and Universities (RTI2018-097534-B-I00) (MCIU/AEI/FEDER,UE), and the Instituto de Salud Carlos III.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

ER stress in mouse serotonin neurons triggers a depressive phenotype alleviated by ketamine targeting eIF2α signaling

  • Miquel-Rio, Lluís
  • Sarries-Serrano, Unai
  • Sancho-Alonso, María
  • Florensa-Zanuy, Eva
  • Paz, Verónica
  • Ruiz-Bronchal, Esther
  • Manashirov, Shanon
  • Campa, Leticia
  • Pilar-Cuéllar, Fuencisla
  • Bortolozzi, Analía
Depression is a devastating mood disorder that causes significant disability worldwide. Current knowledge of its pathophysiology remains modest and clear biological markers are lacking. Emerging evidence from human and animal models reveals persistent alterations in endoplasmic reticulum (ER) homeostasis, suggesting that ER stress-related signaling pathways may be targets for prevention and treatment. However, the neurobiological basis linking the pathways involved in depression-related ER stress remains unknown. Here, we report that an induced model of ER stress in mouse serotonin (5-HT) neurons is associated with reduced Egr1-dependent 5-HT cellular activity and 5-HT neurotransmission, resulting in neuroplasticity deficits in forebrain regions and a depressive-like phenotype. Ketamine administration engages downstream eIF2α signaling to trigger rapid neuroplasticity events that rescue the depressive-like effects. Collectively, these data identify ER stress in 5-HT neurons as a cellular pathway involved in the pathophysiology of depression and show that eIF2α is critical in eliciting ketamine's fast antidepressant effects., This work was supported by MCIU/AEI/FEDER, UE grant ( PID2019-105136RB-100 , MCIN/AEI/10.13039/501100011033 to AB, and SAF2015-67457-R to FPC), Fundación La Marató TV3 ( 202207 ), and AGAUR 2021-SGR-01358 , Catalan Government. CB/07/09/0034 and CB/07/09/0008 Center for Networked Biomedical Research on Mental Health (CIBERSAM). We also thank the Spanish Stress Research Network, MCIN/AEI/10.13039/501100011033. USS is a recipient of a fellowship from the Non-Doctor Researcher Formation Pre-doctoral Program of Basque Government, Spain. MSA has a Margarita Salas Grant ( MS21-132 ) from the University of Valencia (requalification of the Spanish University System of the Ministry of Universities of the Government of Spain, financed by the European Union, Next Generation EU)., Peer reviewed